Clean Yield Group’s Avanos Medical AVNS Stock Holding History

Clean Yield Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7	Closed	–	–	318
2016 Q2	$0	Buy	+7	New	+$214	﹤0.01%	298

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Clean Yield Group's AVNS Position: Q3 2016 in Review

Clean Yield Group sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 7 shares.

Clean Yield Group first reported a position in AVNS in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 358 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

Clean Yield Group reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
Clean Yield Group sold 7 Avanos Medical shares in Q3 2016.
Clean Yield Group first reported a position in Avanos Medical in Q2 2016 and held it in 1 quarter.
Clean Yield Group's Avanos Medical position peaked at $0 in Q2 2016.
358 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Clean Yield Group's 13F filing for Q3 2016, filed 28 Oct 2016.